abstract |
Pharmaceutical preparation for oral administration containing moxifloxacin or a salt and / or hydrate thereof, at least one dry binder, at least one disintegration aid, and at least one lubricating agent, characterized in that the preparation contains 2.5% at 25% lactose Pharmaceutical preparation for oral administration according to claim 1, characterized in that the preparation contains, based on an individual dosage, 50 to 800 mg of moxifloxacin or its salts and / or hydrates. Pharmaceutical preparation for oral administration according to claim 1 or 2, characterized in that the dry binder is microcrystalline cellulose. Pharmaceutical preparation for oral administration according to one of claims 1 to 3, characterized in that the disintegration aid is croscarmellose sodium. Pharmaceutical preparation for oral administration according to any one of claims 1 to 4, characterized in that the lubricating agent is magnesium stearate. |